Get started
Author

Idanna Innocenti

BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199
2016 · Kamil Bojarczuk, Binu K. Sasi, et al. · Blood · 118
PDF
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
2021 · Thomas Chatzikonstantinou, Anargyros Kapetanakis, et al. · Leukemia · 92
PDF
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation
2021 · Supriya Chakraborty, Claudio Martines, et al. · Blood · 66
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression
2020 · Erika Tissino, Federico Pozzo, et al. · Blood · 63
PDF
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
2016 · Massimo Gentile, Tait D. Shanafelt, et al. · Blood · 62
PDF
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study
2016 · Maria Chiara Tisi, Stefan Hohaus, et al. · Haematologica · 59
PDF
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells
2022 · Eugenio Galli, Federica Sorà, et al. · British Journal of Haematology · 53
PDF
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia
2016 · Luciana De Luca, Giovanni D’Arena, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 53
A shorter time to the first treatment may be predicted by the absolute number of regulatory T‐cells in patients with Rai stage 0 chronic lymphocytic leukemia
2012 · Giovanni D'Arena, Fiorella D'Auria, et al. · American Journal of Hematology · 34
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR
2010 · Simona Serini, Valentina Donato, et al. · The Journal of Nutritional Biochemistry · 34
CD200 included in a 4‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia
2018 · Giovanni D'Arena, Candida Vitale, et al. · Hematological Oncology · 32
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
2021 · Francesco Autore, Raffaella Pasquale, et al. · Cancers · 31
PDF
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
2017 · Giovanni D’Arena, Vittorio Simeon, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 30
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
2015 · Luca Laurenti, Idanna Innocenti, et al. · Leukemia Research · 30
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
2014 · A Veronese, F Pepe, et al. · Leukemia · 29
PDF
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma
2017 · Francesca Romana Mauro, Piero Galieni, et al. · American Journal of Hematology · 28
PDF
Role of microRNAs in Chronic Lymphocytic Leukemia
2023 · Francesco Autore, Alice Ramassone, et al. · International Journal of Molecular Sciences · 27
PDF
Second haploidentical stem cell transplantation for primary graft failure
2020 · Sabrina Giammarco, Anna Maria Raiola, et al. · Bone Marrow Transplantation · 25
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia
2020 · Andrea Corbingi, Idanna Innocenti, et al. · British Journal of Haematology · 24
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
2019 · Jared A. Cohen, Francesca Maria Rossi, et al. · Haematologica · 24
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis
2019 · Idanna Innocenti, Francesca Morelli, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 23
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management
2023 · Eugenio Galli, Alberto Fresa, et al. · European Journal Of Haematology · 22
PDF
Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response
2021 · Mirco Di Marco, Serena Veschi, et al. · Cancers · 22
PDF
Comparison between the CLL‐IPI and the B arcelona‐ B rno prognostic model: Analysis of 1299 newly diagnosed cases
2017 · Massimo Gentile, Tait D. Shanafelt, et al. · American Journal of Hematology · 22
PDF
The evolving landscape of COVID ‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC , the European research initiative on CLL
2023 · Andrea Visentin, Thomas Chatzikonstantinou, et al. · American Journal of Hematology · 21
Works count: 205
Citation count: 1,681
H-index: 22
I10-index: 52
Year
Topic
Type